2023

How to transition to e-labelling – practical first steps

by cyb2025

JUTTA HOHENHÖRST
Regional Sales Director, Schlafender Hase, Frankfurt, Germany

ABSTRACT

E-labelling provides patients and healthcare professionals with up-to-date product and safety information. Schlafender Hase’s Dr. Jutta M. Hohenhörst discusses the benefits of e-labelling for the medical device sector and provides some practical tips for getting ahead with processes, procedures and solutions that deliver efficiencies across today’s labelling landscape, and add value for patients.

In the consumer world, it’s now common practice to access product information online. For detailed instructions or information about manufacturing practices, safety advice and so on, users can scan a QR code or go to a web address. This will take them to the latest details, in an easily digestible format – often including audio and video options now, for maximum accessibility.

 

Although the life sciences industry has some way to go to match these ‘e-labelling’ experiences, regulators are making moves to change this through new directives and guidance.

 

ABOUT THE AUTHOR

Dr. Jutta Hohenhörst, Regional Sales Director at Schlafender Hase, has over 22 years’ experience in the pharmaceutical business. She has experience in different departments from Supply Chain Management to Strategic Marketing in F. Hoffmann-La Roche HQ, AstraZeneca and Fresenius HQ. While working for IQVIA during 2005 and 2012 she broadened her knowledge through strategic consulting projects in the pharma, medical device and hospital sector.

Login